{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:32:59Z","timestamp":1792787579552,"version":"4.5.0"},"reference-count":31,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"n\/a"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,5]]},"abstract":"<jats:p>Ribosomes in cancer cells accumulate numerous patient-specific structural and functional modifications that facilitate tumor progression by modifying protein translation. We have taken a unique synthetic chemistry approach to generate novel macrolides, Ribosome modulating agents (RMA), that are proposed to act distal to catalytic sites and exploit cancer ribosome heterogeneity. The RMA ZKN-157 shows two levels of selectivity: (i) selective translation inhibition of a subset of proteins enriched for components of the ribosome and protein translation machinery that are upregulated by MYC; and (ii) selective inhibition of proliferation of a subset of colorectal cancer cell lines. Mechanistically, the selective ribosome targeting in sensitive cells triggered cell-cycle arrest and apoptosis. Consequently, in colorectal cancer, sensitivity to ZKN-157 in cell lines and patient-derived organoids was restricted to the consensus molecular subtype 2 (CMS2) subtype that is distinguished by high MYC and WNT pathway activity. ZKN-157 showed efficacy as single agent and, the potency and efficacy of ZKN-157 synergized with clinically approved DNA-intercalating agents which have previously been shown to inhibit ribogenesis as well. ZKN-157 thus represents a new class of ribosome modulators that display cancer selectivity through specific ribosome inhibition in the CMS2 subtype of colorectal cancer potentially targeting MYC-driven addiction to high protein translation.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study demonstrates that ribosome heterogeneity in cancer can be exploited to develop selective ribogenesis inhibitors. The colorectal cancer CMS2 subtype, with a high unmet need for therapeutics, shows vulnerability to our novel selective ribosome modulator. The mechanism suggests that other cancer subtypes with high MYC activation could also be targeted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0469","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:09:56Z","timestamp":1683720596000},"page":"969-979","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-4210","authenticated-orcid":true,"given":"Esteban","family":"Terzo","sequence":"first","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4556-3036","authenticated-orcid":true,"given":"Shruti A.","family":"Apte","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4925-2917","authenticated-orcid":true,"given":"Simran","family":"Padhye","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-8143","authenticated-orcid":true,"given":"Saleh","family":"Rashed","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-634X","authenticated-orcid":true,"given":"Wesley","family":"Austin","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2268-6789","authenticated-orcid":true,"given":"Michael","family":"Caponegro","sequence":"additional","affiliation":[{"name":"2Vindhya Data Science, Data Science, Morrisville, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1436-3702","authenticated-orcid":true,"given":"Anupama","family":"Reddy","sequence":"additional","affiliation":[{"name":"2Vindhya Data Science, Data Science, Morrisville, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5164-1960","authenticated-orcid":true,"given":"Shuhao","family":"Shi","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4754-5238","authenticated-orcid":true,"given":"Christy","family":"Wang","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7306-1646","authenticated-orcid":true,"given":"Roger B.","family":"Clark","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4178-2072","authenticated-orcid":true,"given":"David","family":"Sidransky","sequence":"additional","affiliation":[{"name":"3Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3720-7553","authenticated-orcid":true,"given":"Vijay","family":"Modur","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3593-966X","authenticated-orcid":true,"given":"Vasudeo","family":"Badarinarayana","sequence":"additional","affiliation":[{"name":"1Eloxx Pharmaceuticals, Watertown, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"2023060514070079200_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.molcel.2018.07.018","article-title":"The discovery of ribosome heterogeneity and its implications for gene regulation and organismal life","volume":"71","author":"Genuth","year":"2018","journal-title":"Mol Cell"},{"key":"2023060514070079200_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41576-018-0008-z","article-title":"Heterogeneity and specialized functions of translation machinery: from genes to organisms","volume":"19","author":"Genuth","year":"2018","journal-title":"Nat Rev Genet"},{"key":"2023060514070079200_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41389-018-0044-8","article-title":"The ribosome, (slow) beating heart of cancer (stem) cell","volume":"7","author":"Bastide","year":"2018","journal-title":"Oncogenesis"},{"key":"2023060514070079200_bib4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13059-016-1104-z","article-title":"Patterns of ribosomal protein expression specify normal and malignant human cells","volume":"17","author":"Guimaraes","year":"2016","journal-title":"Genome Biol"},{"key":"2023060514070079200_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-020-01192-8","article-title":"Disruption of the RNA modifications that target the ribosome translation machinery in human cancer","volume":"19","author":"Janin","year":"2020","journal-title":"Mol Cancer"},{"key":"2023060514070079200_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3389\/fonc.2019.00587","article-title":"Small nucleolar RNAs: insight into their function in cancer","volume":"9","author":"Liang","year":"2019","journal-title":"Front Oncol"},{"key":"2023060514070079200_bib7","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3390\/cancers14092126","article-title":"Targeting ribosome biogenesis in cancer: lessons learned and way forward","volume":"14","author":"Zisi","year":"2022","journal-title":"Cancers"},{"key":"2023060514070079200_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature13737","article-title":"Structural basis for the inhibition of the eukaryotic ribosome","volume":"513","author":"Garreau de Loubresse","year":"2014","journal-title":"Nature"},{"key":"2023060514070079200_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","article-title":"How macrolide antibiotics work","volume":"43","author":"Vazquez-Laslop","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"2023060514070079200_bib10","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41467-021-23068-1","article-title":"Context-specific action of macrolide antibiotics on the eukaryotic ribosome","volume":"12","author":"Svetlov","year":"2021","journal-title":"Nat Commun"},{"key":"2023060514070079200_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature17967","article-title":"A platform for the discovery of new macrolide antibiotics","volume":"533","author":"Seiple","year":"2016","journal-title":"Nature"},{"key":"2023060514070079200_bib12","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"2023060514070079200_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41418-017-0011-5","article-title":"Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models","volume":"25","author":"Linnekamp","year":"2018","journal-title":"Cell Death Differ"},{"key":"2023060514070079200_bib14","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1074\/jbc.M109.074211","article-title":"Chemotherapeutic drugs inhibit ribosome biogenesis at various levels","volume":"285","author":"Burger","year":"2010","journal-title":"J Biol Chem"},{"key":"2023060514070079200_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/2159-8290.CD-14-1326","article-title":"Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis","volume":"5","author":"Van Rechem","year":"2015","journal-title":"Cancer Discov"},{"key":"2023060514070079200_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"2023060514070079200_bib17","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1093\/bioinformatics\/bth456","article-title":"GO::TermFinder\u2013open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes","volume":"20","author":"Boyle","year":"2004","journal-title":"Bioinformatics"},{"key":"2023060514070079200_bib18","doi-asserted-by":"crossref","first-page":"e1005549","DOI":"10.1371\/journal.pcbi.1005549","article-title":"Protein charge distribution in proteomes and its impact on translation","volume":"13","author":"Requiao","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"2023060514070079200_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15698\/cst2018.06.139","article-title":"Nucleolar stress: hallmarks, sensing mechanism and diseases","volume":"2","author":"Yang","year":"2018","journal-title":"Cell Stress"},{"key":"2023060514070079200_bib20","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1007\/s00018-019-03231-0","article-title":"The nucleolus: a central response hub for the stressors that drive cancer progression","volume":"76","author":"Weeks","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"2023060514070079200_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/br.20.4.243-258.1956","article-title":"The calculation of microbial assays","volume":"20","author":"Bliss","year":"1956","journal-title":"Bacteriol Rev"},{"key":"2023060514070079200_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0968-0004(99)01460-7","article-title":"The economics of ribosome biosynthesis in yeast","volume":"24","author":"Warner","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"2023060514070079200_bib23","doi-asserted-by":"crossref","first-page":"9573","DOI":"10.1093\/nar\/gkx673","article-title":"Co-produced natural ketolides methymycin and pikromycin inhibit bacterial growth by preventing synthesis of a limited number of proteins","volume":"45","author":"Almutairi","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2023060514070079200_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/nucl.32235","article-title":"Nucleolar stress with and without p53","volume":"5","author":"James","year":"2014","journal-title":"Nucleus"},{"key":"2023060514070079200_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2478\/raon-2020-0031","article-title":"Consensus molecular subtypes (CMS) in metastatic colorectal cancer \u2013 personalized medicine decision","volume":"54","author":"Rebersek","year":"2020","journal-title":"Radiol Oncol"},{"key":"2023060514070079200_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/msb.2011.82","article-title":"The quantitative proteome of a human cell line","volume":"7","author":"Beck","year":"2011","journal-title":"Mol Syst Biol"},{"key":"2023060514070079200_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.1174294","article-title":"Cell growth and size homeostasis in proliferating animal cells","volume":"325","author":"Tzur","year":"2009","journal-title":"Science"},{"key":"2023060514070079200_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/FPC.0000000000000270","article-title":"PharmGKB summary: macrolide antibiotic pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"2023060514070079200_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/antibiotics9040199","article-title":"Pharmacokinetics of macrolide antibiotics and transport into the interstitial fluid: comparison among erythromycin, clarithromycin, and azithromycin","volume":"9","author":"Kobuchi","year":"2020","journal-title":"Antibiotics"},{"key":"2023060514070079200_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.phrs.2012.06.001","article-title":"Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin","volume":"66","author":"Matijasic","year":"2012","journal-title":"Pharmacol Res"},{"key":"2023060514070079200_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/25.suppl_A.49","article-title":"Pharmacokinetics of azithromycin in rats and dogs","volume":"25","author":"Shepard","year":"1990","journal-title":"J Antimicrob Chemother"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0469\/3330298\/crc-22-0469.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/6\/969\/3338392\/crc-22-0469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/6\/969\/3338392\/crc-22-0469.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T10:08:06Z","timestamp":1685959686000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/6\/969\/727139\/A-Novel-Class-of-Ribosome-Modulating-Agents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,5]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0469","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.22795647.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296043","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296025.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795656","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795644","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296031","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296040.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296022.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795644.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296028.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296016","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296028","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296022","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296046","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296034","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296019","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6639969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296031.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795650","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6639969.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795650.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795653.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296034.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795656.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296019.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296016.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795659.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296037.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795659","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795647","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296049.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296040","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22795653","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6639969.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296043.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296046.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296025","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296037","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296049","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.23296034.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296037.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296019.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296025","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296037","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296049","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296040","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296016","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296028","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296028.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296040.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296031","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296043","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296043.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296046.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296019","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296049.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296016.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296022.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296031.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296022","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296034","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296046","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23296025.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]}}}